Trialect

Verified

Highlighted Topic: Accelerating Otitis Media Research and Workforce Development

National Institutes of Health

Otitis media (OM) is one of the most common childhood illnesses and a leading cause for antibiotic prescriptions in children. More than 80% of children experience at least one episode of OM by three years of age. In children with recurrent or chronic disease, the impact on development can be substantial, including prolonged conductive hearing loss and delays in speech, language, and learning. OM has a significant disease burden, including care-giver strain and health care costs. In the United States alone, annual health care costs associated with OM are estimated at over $4.5 billion. Current prevention strategies consist primarily of the pneumococcal conjugate vaccine, which has had modest effects on OM incidence due to pathogen replacement. Furthermore, the factors that make some children susceptible to OM while others remain resistant are not well understood. Research into the factors that contribute to OM-resistance may be critical to developing prevention strategies. Finally, expanded and innovative treatment options, beyond antibiotics and pressure equalization tubes, are needed to address this public health challenge.

Taken together, OM imposes a substantial disease burden that demands expanded research capacity and innovation. NIH is committed to accelerating basic, clinical, and translational OM research and cultivating the next generation of investigators.

Capacity building areas of interest include, but are not limited to, the following:

Mentored research training experiences for pre- and post-doctoral trainees in projects focused on OM.
Early-stage researchers in the initial stages of building a research program in OM.
Investigators at all career stages that are interested in connecting or redirecting their current scientific programs (e.g., biofilm, metabolomics, genomics, pathogenesis, immunity, pharmacology, infectious disease, epidemiology, bioinformatics, etc.) to research directly related to OM.

Scientific topics of interest include, but are not limited to, epidemiology, etiology, pathophysiology, diagnosis, prevention, and treatment of OM.

Apply through an appropriate NIH Parent Funding Announcement or another broad NIH opportunity available on Grants.gov .

Expiration Date: May 26, 2028

Specialties

Curriculum Development

Medical - Basic Science

Medical - Translational

Medical

Medical - Clinical Science

Eligibility Requirements

Sponsor Details

Sponsor Institute/Organizations: National Institutes of Health

Sponsor Type: Government/Federal

Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity